FDA/CDRH: Proposed Guidances for FY 2022
The FDA’s Center for Devices and Radiological Health (CDRH) has published its lists with guidance documents intended to be published next year. At this stage CDRH is interested in receiving external feedback on whether the listed documents should be revised or withdrawn.
The documents have been split into three lists:
- The A-list, for prioritized device guidance documents the FDA intends to publish during the fiscal year 2022
- The B-list, for device guidance documents the FDA intends to publish as resources permit during the fiscal year 2022
- A retrospective review list with final guidance documents issued in 1982, 1992, 2002, and 2012, with an option for withdrawl
Electronic comments can be submitted to www.regulations.gov.
Source:
FDA/CDRH: Proposed Guidelines for FY 2022
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
